Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD

Crohn’s & Colitis Foundation Perspectives

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Maria M. Oliva-Hemker, MD
With current treatment approaches in mind, how do immunomodulators fit into the therapeutic landscape for inflammatory bowel disorders, or IBD? In preparation for the 2021 Crohn’s & Colitis Congress, Dr. Charles Turck speaks with Dr. Maria Oliva-Hemker from Johns Hopkins University School of Medicine about her presentation at the event.